We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Adient
ADNT
$1.6B
| $1.3M | 0.01% |
+79,037
| New | +$1.2M |
|
927
Viavi Solutions
VIAV
$9.75B
| $1.29M | 0.01% |
+101,112
| New | +$1.21M |
|
|
BBT
928
Beacon Financial Corp
BBT
$2.53B
| $1.28M | 0.01% |
+115,765
| New | +$1.49M |
|
929
WPP
WPP
$4.04B
| $1.27M | 0.01% |
+32,560
| New | +$1.21M |
|
930
GE Aerospace
GE
$367B
| $1.27M | 0.01% |
37,416
+36,116
| +2,778% | +$1.22M |
|
|
VEDL
931
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $1.27M | 0.01% |
225,883
+197,683
| +701% | +$935K |
|
932
Par Pacific Holdings
PARR
$3.88B
| $1.26M | 0.01% |
140,264
-121,032
| -46% | -$1.04M |
|
933
PUT
iShares MSCI Mexico ETF
EWW
$1.89B
| $1.26M | 0.01% |
+37,100
| New | +$1.13M |
|
934
Arvinas
ARVN
$518M
| $1.26M | 0.01% |
+37,447
| New | +$1.59M |
|
935
Iron Mountain
IRM
$38.2B
| $1.25M | 0.01% |
48,068
+47,306
| +6,208% | +$1.19M |
|
936
W.P. Carey
WPC
$17.1B
| $1.25M | 0.01% |
18,838
+16,909
| +877% | +$1.05M |
|
937
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $1.22M | 0.01% |
31,892
+1,246
| +4% | +$45.6K |
|
938
Shutterstock
SSTK
$205M
| $1.22M | 0.01% |
34,985
-36,440
| -51% | -$1.31M |
|
939
Boston Omaha
BOC
$429M
| $1.22M | 0.01% |
+76,250
| New | +$1.27M |
|
|
BRFS
940
DELISTED
BRF SA
BRFS
| $1.22M | 0.01% |
307,300
-188,310
| -38% | -$726K |
|
941
Voyager Therapeutics
VYGR
$187M
| $1.21M | 0.01% |
95,954
-98,490
| -51% | -$1.15M |
|
942
Ameriprise Financial
AMP
$46.8B
| $1.21M | 0.01% |
8,064
+7,734
| +2,344% | +$992K |
|
943
Aflac
AFL
$63.9B
| $1.21M | 0.01% |
33,559
-166,396
| -83% | -$6.01M |
|
944
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $1.21M | 0.01% |
42,484
-231,590
| -84% | -$6.33M |
|
|
OPLN
945
Openlane
OPLN
$4.17B
| $1.2M | 0.01% |
+87,299
| New | +$1.2M |
|
946
Dianthus Therapeutics
DNTH
$5.68B
| $1.2M | 0.01% |
+9,951
| New | +$1.4M |
|
|
EPZM
947
DELISTED
Epizyme, Inc
EPZM
| $1.2M | 0.01% |
74,397
+36,158
| +95% | +$631K |
|
948
Rogers Corp
ROG
$2.33B
| $1.19M | 0.01% |
9,579
+2,036
| +27% | +$218K |
|
949
Accuray
ARAY
$28.4M
| $1.19M | 0.01% |
587,063
-55,034
| -9% | -$115K |
|
950
Huntington Ingalls Industries
HII
$11.3B
| $1.19M | 0.01% |
+6,791
| New | +$1.26M |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.